宣传图

loncom front page
loncom full view 1
loncom full view 2
loncom full view 3

Product Category

APIs, Finished Preparation, Intermediate

About Us

Promote Human Health
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan. Loncom Pharma adheres to the R&D spirit of "Being rigorous, serious, focused and realistic", and takes ICH international guidelines as the standard to produce formulations and APIs continuously. At present, the company's products have covered cardiovascular and cerebrovascular system, digestive system, anti-tumor, nervous system, geriatric medicine, andrology medicine, pediatric medicine and other fields.

Core Product

Loncom Pharma has three API production workshops GMP certified by the state, as well as three production lines for tablets, hard capsules, dry suspensions and oral liquid preparations.
Upadacitinib
CAS No.:1310726-60-3
Formula:C17H19F3N6O
Type:Pharmaceutical API
Appearance:Powder
Certificate:GMP, COPP, WC, DMF
Shelf Life:2 years
Quality Standard:CP, EP, JP, USP
Assay:98.0%-102.0%
Chemical Name:(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo [7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
View More
Linzagolix Choline
CAS No.:1321816-57-2
Formula:C27H28F3N3O8S
Type:Pharmaceutical API
Appearance:
Certificate:GMP,  DMF
Shelf Life:2 years
Quality Standard:CP, EP, USP
Assay:97.0%-102.0%
Chemical Name:3-[5-[(2,3-difluoro-6-methoxyphenyl)methoxy]-2-fluoro-4-methoxyphenyl]-2,4-dioxo-1H-thieno[3,4-d]pyrimidine-5-carboxylate;2-hydroxyethyl(trimethyl)azanium
View More
Varenicline Tartrate
CAS No.: 375815-87-5
Formula: C17H19N3O6
Type: Pharmaceutical API
Appearance: Powder
Certificate: GMP, COPP, WC, DMF
Shelf Life 2 years
Quality Standard CP, EP, JP, USP
Assay 98.0%-102.0%
Chemical Name 2R,3R)-2,3-dihydroxybutanedioic acid;5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene
View More
Elagolix Sodium
CAS No.:832720-36-2
Formula:C32H29F5N3NaO5
Type:Pharmaceutical API
Appearance:Powder
Certificate:GMP, COPP, WC, DMF
Shelf Life:2 years
Quality Standard:CP, EP, JP, USP
Assay:98.0%-102.0%
Chemical Name:sodium;4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoate
View More
Daprodustat
CAS No.:960539-70-2
Formula:C19H27N3O6
Type:Pharmaceutical API
Appearance:Powder
Certificate:GMP, COPP, WC, DMF
Shelf Life:2 years
Quality Standard:CP, EP, JP, USP
Assay:98.0%-102.0%
Chemical Name:2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic acid
View More
Perampanel
CAS No.:380917-97-5
Formula:C23H15N3O
Type:Pharmaceutical API
Appearance:Powder
Certificate:GMP, COPP, WC, DMF
Shelf Life:2 years
Quality Standard:CP, EP, JP, USP
Assay:98.0%-102.0%
Chemical Name:2-(2-oxo-1-phenyl-5-pyridin-2-ylpyridin-3-yl)benzonitrile
View More
Dotinurad
CAS No.: 1285572-51-1
Formula: C14H9Cl2NO4S
Type: Pharmaceutical API
Appearance: Powder
Certificate: GMP, COPP, WC, DMF
Shelf Life 2 years
Quality Standard CP, EP, JP, USP
Assay 98.0%-102.0%
Chemical Name :(3,5-dichloro-4-hydroxyphenyl)-(1,1-dioxo-2H-1,3-benzothiazol-3-yl)methanone
View More
Osimertinib Mesylate
CAS No.:1421373-66-1
Formula:C29H37N7O5S
Type:Pharmaceutical API
Appearance:Powder
Certificate:GMP, COPP, WC, DMF
Shelf Life:2 years
Quality Standard:CP, EP, JP, USP
Assay:98.0%-102.0%
Chemical Name:N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide;methanesulfonic acid
View More

Our Service

Stable, Professional, And Efficient Service

News of LONCOM - High-tech Pharmaceutical Company

10/ 29/ 2026
China Pharma Plan 2026-2030: Innovation and Global Reach

China published its 15th Five-Year Plan for the pharmaceutical industry on 18 September 2026, setting ten 2030 targets and 25 key tasks on innovation, resilient supply chains and international expansion.

no photo
10/ 22/ 2026
ICH M13B Final Guideline: Additional Strength Biowaivers

EMA's final ICH M13B guideline, published 21 September 2026 and effective 17 March 2027, sets the criteria for waiving in vivo bioequivalence studies for additional strengths of immediate-release oral solids.

no photo
10/ 19/ 2026
PIC/S GMP Annex 19 Update: Reference and Retention Samples

PIC/S revises GMP Annex 19, clarifying sample retention, repackaging requirements, digital records, and traceability for parallel-traded medicinal products.

no photo
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong, China

QUICK LINKS

PRODUCT CATEGORY

Copyright © 2023 Shandong Loncom Pharmaceutical Co., Ltd. All Rights Reserved. Sitemap | Privacy Policy
Supported by leadong.com
Contact Us